An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
Clinical trial NCT04520308 · UNKNOWN
Trial details
- NCT number
- NCT04520308
- Sponsor
- Eric Simpson
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2021-02-26
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.